I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Anti-VEGF treatment reduces blood supply and increases tumo..:
Keunen, Olivier
;
Johansson, Mikael
;
Oudin, Anaïs
...
urn:issn:0027-8424. , 2011
Link:
https://orbilu.uni.lu/handle/10993/60231
RT Journal T1
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
UL https://suche.suub.uni-bremen.de/peid=base-ftunivluxembourg:oai:orbilu.uni.lu:10993_60231&Exemplar=1&LAN=DE A1 Keunen, Olivier A1 Johansson, Mikael A1 Oudin, Anaïs A1 Sanzey, Morgane A1 Rahim, Siti A Abdul A1 Fack, Fred A1 Thorsen, Frits A1 Taxt, Torfinn A1 Bartos, Michal A1 Jirik, Radovan A1 Miletic, Hrvoje A1 Wang, Jian A1 Stieber, Daniel A1 Stuhr, Linda A1 Moen, Ingrid A1 Rygh, Cecilie Brekke A1 Bjerkvig, Rolf A1 NICLOU, Simone P PB National Academy of Sciences YR 2011 K1 Antibodies K1 Monoclonal K1 Humanized K1 Contrast Media K1 Vascular Endothelial Growth Factor A K1 Wnt Proteins K1 2S9ZZM9Q9V (Bevacizumab) K1 EC 2.7.1.- (Phosphatidylinositol 3-Kinases) K1 Animals K1 Monoclonal/pharmacology/therapeutic use K1 Bevacizumab K1 Blood Volume/drug effects K1 Capillary Permeability/drug effects K1 Cell Hypoxia/drug effects K1 Disease Progression K1 Enzyme Activation/drug effects K1 Glioblastoma/blood supply/enzymology/pathology/ultrastructure K1 Humans K1 Magnetic Resonance Imaging K1 Neoplasm Invasiveness K1 Neovascularization K1 Pathologic/drug therapy/pathology K1 Phosphatidylinositol 3-Kinases/metabolism K1 Rats K1 Nude K1 Signal Transduction/drug effects K1 Vascular Endothelial Growth Factor A/antagonists & inhibitors/metabolism K1 Wnt Proteins/metabolism K1 Xenograft Model Antitumor Assays K1 Human health sciences K1 Oncology K1 Sciences de la santé humaine K1 Oncologie JF urn:issn:0027-8424 LK http://dx.doi.org/https://orbilu.uni.lu/handle/10993/60231 DO https://orbilu.uni.lu/handle/10993/60231 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)